Black Diamond Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDTX and other ETFs, options, and stocks.About BDTX
Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases.
BDTX Key Statistics
Stock Snapshot
The current Black Diamond Therapeutics(BDTX) stock price is $2.16, with a market capitalization of 123.46M. The stock trades at a price-to-earnings (P/E) ratio of 5.74.
On 2026-03-18, Black Diamond Therapeutics(BDTX) stock moved within a range of $2.13 to $2.26. With shares now at $2.16, the stock is trading +1.4% above its intraday low and -4.7% below the session's peak.
Trading activity shows a volume of 400.13K, compared to an average daily volume of 786.25K.
Over the past 52 weeks, Black Diamond Therapeutics(BDTX) stock has traded between a high of $4.94 and a low of $1.20.
Over the past 52 weeks, Black Diamond Therapeutics(BDTX) stock has traded between a high of $4.94 and a low of $1.20.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.